Catherine H. Marshall

3.9k total citations · 1 hit paper
67 papers, 1.3k citations indexed

About

Catherine H. Marshall is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Catherine H. Marshall has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Catherine H. Marshall's work include Prostate Cancer Treatment and Research (35 papers), PARP inhibition in cancer therapy (16 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Catherine H. Marshall is often cited by papers focused on Prostate Cancer Treatment and Research (35 papers), PARP inhibition in cancer therapy (16 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Catherine H. Marshall collaborates with scholars based in United States, Brazil and Spain. Catherine H. Marshall's co-authors include Emmanuel S. Antonarakis, Hao Wang, Mario A. Eisenberger, Anna R. Gagliardi, Sue Huckson, Roberta James, Tamara L. Lotan, Wei Fu, Michael T. Schweizer and Alexandra Sokolova and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Catherine H. Marshall

65 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Unprocessed Red Meat and Processed Meat Consumption: Dietary Guideline Recommendations From the Nutritional Recommendations (NutriRECS) Consortium

2019 202 citations Bradley C. Johnston, Dena Zeraatkar et al. profile →

Peers

Countries citing papers authored by Catherine H. Marshall

Since Specialization

Citations

This map shows the geographic impact of Catherine H. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine H. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine H. Marshall more than expected).

Fields of papers citing papers by Catherine H. Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine H. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine H. Marshall. The network helps show where Catherine H. Marshall may publish in the future.

Co-authorship network of co-authors of Catherine H. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine H. Marshall. A scholar is included among the top collaborators of Catherine H. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine H. Marshall. Catherine H. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated Cancers 2025 ·Cancers ·Catherine H. Marshall, (unknown), (unknown), Stamatina Fragkogianni, (unknown), (unknown), Lukasz P. Gondek, Calvin Chao, Jun Luo, Emmanuel S. Antonarakis	0
2	Assessment of PARP1 mRNA expression as prognostic of aggressive pathology and adverse outcomes, and as predictor of response to PARP inhibition in castration-sensitive prostate cancer. 2025 ·Journal of Clinical Oncology ·Emmanuel S. Antonarakis, Mohammed Alshalalfa, Benjamin A. Teply, Yangyang Hao, J. Proudfoot, Elai Davicioni, Edward M. Schaeffer, R. Jeffrey Karnes, Daniel E. Spratt, Justin H. Hwang, Tamara L. Lotan, Catherine H. Marshall	2
3	Radiotherapeutics, clonal hematopoiesis, and risk of hematologic malignancies: The good, the bad, the ugly 2025 ·Blood Reviews ·Catherine H. Marshall, Emmanuel S. Antonarakis, Mrinal M. Patnaik	2
4	Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey‐Holden Prostate Cancer Academy Meeting 2024 ·The Prostate ·Andrea K. Miyahira, Sophia C. Kamran, (unknown), Catherine H. Marshall, (unknown), Abhijit Parolia, Nicholas A. Zorko, Kenneth J. Pienta, Howard R. Soule	1
5	Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer 2024 ·The Prostate ·Catherine H. Marshall, Lukasz P. Gondek, (unknown), Changxue Lu, Sergiu Paşca, (unknown), Mark C. Markowski, Channing J. Paller, Laura A. Sena, Samuel R. Denmeade, Jun Luo, Emmanuel S. Antonarakis	10
6	Association of SGLT2 Inhibitor Initiation and PSA Response in Prostate Cancer 2024 ·The Prostate ·(unknown), Michael A. Carducci, Channing J. Paller, Samuel R. Denmeade, (unknown), Catherine H. Marshall, Mark C. Markowski	2
7	A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer 2024 ·Prostate Cancer and Prostatic Diseases ·Neal D. Shore, Emmanuel S. Antonarakis, Ashley E. Ross, Catherine H. Marshall, Kelly Stratton, (unknown), Michael S. Cookson, Rana R. McKay, Alan H. Bryce, Marina D. Kaymakcalan	1
8	Prospective Characterization of Circulating Tumor Cells in Hormone Sensitive Oligometastatic Prostate Cancer Patients on a Metastasis-Directed Therapy Trial 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), (unknown), Matthew P. Deek, Noura Radwan, Catherine H. Marshall, Mark V. Mishra, (unknown), Jason K. Molitoris, Young Kwok, Santosh Gupta, (unknown), (unknown), Daniel Y. Song, Felix Y. Feng, Kenneth J. Pienta, Emmanuel S. Antonarakis, Ana P. Kiess, (unknown)	1
9	MSR154 Qualitative Content Analysis for Concept Elicitation (CACE) in Clinical Outcome Assessment Development 2023 ·Value in Health ·(unknown), Elizabeth Collins, Catherine H. Marshall, (unknown)	1
10	Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies 2022 ·Cancer Research ·Catherine H. Marshall, Lukasz P. Gondek, Jun Luo, Emmanuel S. Antonarakis	20
11	Bridging the gap to advance the care of individuals with cancer: collaboration and partnership in the Cardiology Oncology Innovation Network (COIN) 2022 ·Cardio-Oncology ·Sherry‐Ann Brown, Craig J. Beavers, Hugo R. Martinez, Catherine H. Marshall, (unknown), Avirup Guha, David Cho, Alison Bailey, Carmen Bergom, Neha Bansal, (unknown), Richard K. Cheng	10
12	Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer 2021 ·Clinical Cancer Research ·Catherine H. Marshall, Wei Fu, Hao Wang, Jong Chul Park, Theodore L. DeWeese, Phuoc T. Tran, Daniel Y. Song, (unknown), (unknown), (unknown), (unknown), (unknown), Nancy P. Moldawer, Pedro C. Barata, Charles G. Drake, Edwin M. Posadas, Andrew J. Armstrong, Oliver Sartor, Emmanuel S. Antonarakis	39
13	Fitness and prostate cancer screening, incidence, and mortality: Results from the Henry Ford Exercise Testing (FIT) Project 2021 ·Cancer ·Cara Reiter–Brennan, Omar Dzaye, Mouaz H. Al‐Mallah, Zeina Dardari, Clinton A. Brawner, Lois Lamerato, Steven J. Keteyian, Jonathan K. Ehrman, Michael J. Blaha, Kala Visvanathan, Catherine H. Marshall	9
14	Extreme Responses to a Combination of DNA-Damaging Therapy and Immunotherapy in CDK12-Altered Metastatic Castration-Resistant Prostate Cancer: A Potential Therapeutic Vulnerability 2021 ·Clinical Genitourinary Cancer ·(unknown), Catherine H. Marshall, Pedro Isaacsson Velho, (unknown), José Flávio Gomes Marin, Anamaria A. Camargo, Diogo Assed Bastos, Emmanuel S. Antonarakis	5
15	Association between coronary artery calcium and cardiovascular disease as a supporting cause in cancer: The CAC consortium 2020 ·SHILAP Revista de lepidopterología ·Frances Wang, Cara Reiter–Brennan, Zeina Dardari, Catherine H. Marshall, Khurram Nasir, Michael D. Miedema, Daniel S. Berman, Alan Rozanski, John A. Rumberger, Matthew J. Budoff, Omar Dzaye, Michael J. Blaha	13
16	Coronary Artery Calcium and the Age-Specific Competing Risk of Cardiovascular Versus Cancer Mortality: The Coronary Artery Calcium Consortium 2020 ·The American Journal of Medicine ·Seamus P. Whelton, Mahmoud Al Rifai, Catherine H. Marshall, Zeina Dardari, Leslee J. Shaw, Mouaz H. Al‐Mallah, Alan Rozanski, Martin Bødtker Mortensen, Omar Dzaye, Lydia Bazzano, Tanika N. Kelly, Kunihiro Matsushita, John A. Rumberger, Daniel S. Berman, Matthew J. Budoff, Michael D. Miedema, Khurram Nasir, Michael J. Blaha	14
17	Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer 2019 ·European Urology ·Pedro Isaacsson Velho, Wei Fu, Hao Wang, Nooshin Mirkheshti, Fahad Qazi, (unknown), Farah Shaukat, Michael A. Carducci, Samuel R. Denmeade, Channing J. Paller, Mark C. Markowski, Catherine H. Marshall, Mario A. Eisenberger, Emmanuel S. Antonarakis	66
18	Just Beneath the Surface 2018 ·New England Journal of Medicine ·Catherine H. Marshall, (unknown), (unknown), Allan C. Gelber	2
19	Methods for trustworthy nutritional recommendations NutriRECS (Nutritional Recommendations and accessible Evidence summaries Composed of Systematic reviews): a protocol 2018 ·BMC Medical Research Methodology ·Bradley C. Johnston, Pablo Alonso‐Coello, Małgorzata M Bała, Dena Zeraatkar, Montserrat Rabassa, Claudia Valli, Catherine H. Marshall, Regina El Dib, Robin W.M. Vernooij, Per Olav Vandvik, Gordon Guyatt	31
20	Patient and public involvement in clinical guidelines: international experiences and future perspectives 2010 ·BMJ Quality & Safety ·Antoine Boivin, Kay Currie, Bèatrice Fervers, Javier Gracia Calandín, (unknown), Catherine H. Marshall, Carol Sakala, S. Sänger, (unknown), Victoria Thomas, Trudy van der Weijden, Richard Grol, Jako Burgers, (unknown)	148

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact